Clinical Trial Update: Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating conjugated estrogen cream for vaginal atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Atrophy

Drugs mentioned

• Premarin Vaginal Cream (conjugated estrogens)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Atrophic Vaginitis, Atrophy | Phase 3 | Status: COMPLETED